Literature DB >> 34145341

High level of fatty liver index predicts new onset of diabetes mellitus during a 10-year period in healthy subjects.

Yukimura Higashiura1, Masato Furuhashi2, Marenao Tanaka1, Satoko Takahashi1, Masayuki Koyama1,3, Hirofumi Ohnishi1,3, Keita Numata4, Takashi Hisasue4, Nagisa Hanawa4, Norihito Moniwa1, Kazufumi Tsuchihashi1, Tetsuji Miura1.   

Abstract

Fatty liver index (FLI), a predictor of nonalcoholic fatty liver disease, has been reported to be associated with several metabolic disorders. This study aimed to evaluate the relationship between FLI and new onset of diabetes mellitus (DM). We investigated the association of FLI with new onset of DM during a 10-year period in subjects who received annual health examinations (n = 28,990). After exclusion of subjects with DM at baseline and those with missing data, a total of 12,290 subjects (male/female: 7925/4365) who received health examinations were recruited. FLI was significantly higher in males than in females. During the 10-year period, DM was developed in 533 males (6.7%) and 128 females (2.9%). Multivariable Cox proportional hazard models with a restricted cubic spline showed that the risk of new onset of DM increased with a higher FLI at baseline in both sexes after adjustment of age, fasting plasma glucose, habits of alcohol drinking and current smoking, family history of DM and diagnosis of hypertension and dyslipidemia at baseline. When the subjects were divided into subgroups according to tertiles of FLI level at baseline (T1-T3) in the absence and presence of impaired fasting glucose (IFG), hazard ratios after adjustment of the confounders gradually increased from T1 to T3 and from the absence to presence of IFG in both male and female subjects. In conclusion, a high level of FLI predicts new onset of DM in a general population of both male and female individuals.

Entities:  

Year:  2021        PMID: 34145341     DOI: 10.1038/s41598-021-92292-y

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  44 in total

1.  Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030.

Authors:  Chris Estes; Quentin M Anstee; Maria Teresa Arias-Loste; Heike Bantel; Stefano Bellentani; Joan Caballeria; Massimo Colombo; Antonio Craxi; Javier Crespo; Christopher P Day; Yuichiro Eguchi; Andreas Geier; Loreta A Kondili; Daniela C Kroy; Jeffrey V Lazarus; Rohit Loomba; Michael P Manns; Giulio Marchesini; Atsushi Nakajima; Francesco Negro; Salvatore Petta; Vlad Ratziu; Manuel Romero-Gomez; Arun Sanyal; Jörn M Schattenberg; Frank Tacke; Junko Tanaka; Christian Trautwein; Lai Wei; Stefan Zeuzem; Homie Razavi
Journal:  J Hepatol       Date:  2018-06-08       Impact factor: 25.083

Review 2.  Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research.

Authors:  Benjamin M Leon; Thomas M Maddox
Journal:  World J Diabetes       Date:  2015-10-10

Review 3.  2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.

Authors:  Francesco Cosentino; Peter J Grant; Victor Aboyans; Clifford J Bailey; Antonio Ceriello; Victoria Delgado; Massimo Federici; Gerasimos Filippatos; Diederick E Grobbee; Tina Birgitte Hansen; Heikki V Huikuri; Isabelle Johansson; Peter Jüni; Maddalena Lettino; Nikolaus Marx; Linda G Mellbin; Carl J Östgren; Bianca Rocca; Marco Roffi; Naveed Sattar; Petar M Seferović; Miguel Sousa-Uva; Paul Valensi; David C Wheeler
Journal:  Eur Heart J       Date:  2020-01-07       Impact factor: 29.983

Review 4.  Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome.

Authors:  Amedeo Lonardo; Stefano Ballestri; Giulio Marchesini; Paul Angulo; Paola Loria
Journal:  Dig Liver Dis       Date:  2014-11-18       Impact factor: 4.088

5.  IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040.

Authors:  K Ogurtsova; J D da Rocha Fernandes; Y Huang; U Linnenkamp; L Guariguata; N H Cho; D Cavan; J E Shaw; L E Makaroff
Journal:  Diabetes Res Clin Pract       Date:  2017-03-31       Impact factor: 5.602

6.  Cohort study of non-alcoholic fatty liver disease, NAFLD fibrosis score, and the risk of incident diabetes in a Korean population.

Authors:  Yoosoo Chang; Hyun-Suk Jung; Kyung Eun Yun; Juhee Cho; Yong Kyun Cho; Seungho Ryu
Journal:  Am J Gastroenterol       Date:  2013-10-08       Impact factor: 10.864

7.  The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe.

Authors:  Zobair M Younossi; Deirdre Blissett; Robert Blissett; Linda Henry; Maria Stepanova; Youssef Younossi; Andrei Racila; Sharon Hunt; Rachel Beckerman
Journal:  Hepatology       Date:  2016-09-26       Impact factor: 17.425

Review 8.  Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis.

Authors:  Stefano Ballestri; Stefano Zona; Giovanni Targher; Dante Romagnoli; Enrica Baldelli; Fabio Nascimbeni; Alberto Roverato; Giovanni Guaraldi; Amedeo Lonardo
Journal:  J Gastroenterol Hepatol       Date:  2016-05       Impact factor: 4.029

9.  Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus.

Authors:  J Partanen; L Niskanen; J Lehtinen; E Mervaala; O Siitonen; M Uusitupa
Journal:  N Engl J Med       Date:  1995-07-13       Impact factor: 91.245

10.  Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance.

Authors:  Kuen Cheh Yang; Hui-Fang Hung; Chia-Wen Lu; Hao-Hsiang Chang; Long-Teng Lee; Kuo-Chin Huang
Journal:  Sci Rep       Date:  2016-06-01       Impact factor: 4.379

View more
  5 in total

1.  High fibrosis-4 index predicts the new onset of ischaemic heart disease during a 10-year period in a general population.

Authors:  Yukimura Higashiura; Marenao Tanaka; Kazuma Mori; Takuma Mikami; Itaru Hosaka; Hirofumi Ohnishi; Nagisa Hanawa; Masato Furuhashi
Journal:  Eur Heart J Open       Date:  2022-04-16

2.  Fatty liver index for hyperuricemia diagnosis: a community-based cohort study.

Authors:  Jianchang Qu; Jingtao Dou; Anping Wang; Yingshu Liu; Lu Lin; Kang Chen; Li Zang; Yiming Mu
Journal:  BMC Endocr Disord       Date:  2022-04-30       Impact factor: 3.263

3.  Circulating level of fatty acid-binding protein 4 is an independent predictor of metabolic dysfunction-associated fatty liver disease in middle-aged and elderly individuals.

Authors:  Marenao Tanaka; Satoko Takahashi; Yukimura Higashiura; Akiko Sakai; Masayuki Koyama; Shigeyuki Saitoh; Kazuaki Shimamoto; Hirofumi Ohnishi; Masato Furuhashi
Journal:  J Diabetes Investig       Date:  2022-01-03       Impact factor: 3.681

4.  Fatty Liver Index is a valid predictor of non-alcoholic fatty liver disease (NAFLD) in pregnancy.

Authors:  Iresha Sandamali Koralegedara; Janith Niwanthaka Warnasekara; Ashani Rathnayake; Korale Gedara Dayaratne; Suneth Buddhika Agampodi
Journal:  BMJ Open Gastroenterol       Date:  2022-06

5.  Circulating PCSK7 Level is Independently Associated with Obesity, Triglycerides Level and Fatty Liver Index in a General Population without Medication.

Authors:  Masato Furuhashi; Yu Kataoka; Ryo Nishikawa; Masayuki Koyama; Akiko Sakai; Yukimura Higashiura; Marenao Tanaka; Shigeyuki Saitoh; Kazuaki Shimamoto; Hirofumi Ohnishi
Journal:  J Atheroscler Thromb       Date:  2021-09-25       Impact factor: 4.394

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.